secwatch.observer — SEC 8-K summary
======================================

Issuer:     MetaVia Inc. (MTVA)
CIK:        0001638287
Form:       8-K
Filed at:   2026-01-16T23:59:59+00:00
Accession:  0001104659-26-004532
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

MetaVia closes $9.3M public offering with full over-allotment; net proceeds ~$7.7M for DA-1726
--------------------------------------------------------------------------------

- Closed offering of 3,005,574 shares/equivalents + 4,508,361 Series C and Series D Warrants at $3.10 each.
- Net proceeds to MetaVia approximately $7.7 million after underwriting discounts and expenses.
- Series C Warrants ($3.10 exercise, 5-year term); Series D Warrants ($3.10 exercise, 2-year term, callable).
- Series D Warrants callable after positive Phase 1b Part III data for DA-1726 and stock price >$4.65 for 20 days.
- Proceeds to fund working capital and clinical development of DA-1726 for obesity treatment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638287/000110465926004532/0001104659-26-004532-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638287/000110465926004532/tm263364d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-004532

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer